| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |